News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Daily News mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events Michael O'Riordan September 26, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Daily News After COVID-19, Unvaccinated at Risk for Long-term CVD Complications Michael O'Riordan August 16, 2022
News Daily News ‘Stunning’ Cost Variability Across Centers for Common Cardiac Tests, Procedures Michael O'Riordan July 21, 2022
News Conference News TVT 2022 More Support for Single Antiplatelet Therapy After TAVI Michael O'Riordan June 10, 2022
News Conference News EuroPCR 2022 MitraClip Helps for Atrial Functional MR: MITRA-TUNE Michael O'Riordan May 19, 2022
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News ACC 2022 Most Infected Cardiac Implanted Electronic Devices Not Removed Fast Enough Michael O'Riordan April 04, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News ‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible Michael O'Riordan March 21, 2022